Compliance with the new EU MDR and IVDR

Publish date:

Medical and in-vitro diagnostic device manufacturers must meet strict deadlines over the next three years if they are to implement new compliance strategies without affecting the time to market of new products.

The need to strengthen the regulatory platform across the European Union (EU) is driven by the need to ensure patient safety and device performance. The new Medical Device Regulations (MDR) and In-Vitro Diagnostic Regulations (IVDR) regulations seek to harmonize the regulations to improve transparency and product traceability.

Regulatory changes are an effective step towards enabling the Intelligent Industry. Capgemini helps organizations transition smoothly to the new EU
MDR/IVDR requirements by offering a customized strategic approach, from gap assessment to lifecycle management support.



File size: 523.23 KB File type: PDF

Related Resources

Digital Engineering and Manufacturing Service

Solutions for Medical Devices Digital Technical Publications

The implementation of the new Medical Device Regulation (MDR), the In-Vitro Diagnostic...

Digital Engineering and Manufacturing Service

Solutions for Medical Devices and Healthcare

Capgemini’s medical device engineering practice brings solutions and services that help our...

Digital Engineering and Manufacturing Service

Envisioning Cardiac Electrophysiology with Artificial Intelligence

Cardiac arrhythmias are a major global healthcare problem and there is significant scope for...